Researchers identify genetic mechanisms involved in a disorder that affects balance cells in the ear
The research explains how the loss of balance cells in the ear begins with the continued use of some antibiotics and other drugs.
2025
Dr. Núria Lloberas, new president of the IATDMCT Immunosuppression Committee
The Committee that Dr. Lloberas will lead is responsible for drawing up international consensus and guidelines on the use and monitoring of immunosuppressive drugs.
Dr. Núria Lloberas, new president of the IATDMCT Immunosuppression Committee Read More »
Bellvitge Health Campus provides comprehensive cancer care to two million people, following the model that Europe aims to deploy by 2030
Bellvitge Health Campus has been accredited as a Comprehensive Cancer Centre (CCC), the highest European recognition for the integrated approach to cancer care.
Researchers from IRBLleida and IDIBELL identify key molecules in endometrial cancer
This is a key advance in the design of new treatments that can address common diseases among women, such as endometrial cancer and endometriosis.
Researchers from IRBLleida and IDIBELL identify key molecules in endometrial cancer Read More »
A collaborative study identifies metabolic profiles in platelets with potential to predict ALS progression
A pilot study by IRBLleida and IDIBELL identifies metabolic and lipid profiles in platelets with potential to predict the rate of evolution of ALS.
IDIBELL consolidates its scientific excellence with 33 researchers on the World’s Top 2% Scientists list
Of the 33 IDIBELL researchers included this year, 6 are positioned in the top 5 in Spain and Catalonia for their scientific career, and 4 do so for their impact during 2024.
International study opens door to new standard treatment for head and neck cancer
Adding immunotherapy to the usual treatment with cisplatin and radiotherapy after surgery significantly increases disease-free survival in high-risk patients with head and neck cancer.
International study opens door to new standard treatment for head and neck cancer Read More »
[RE]accions Bellvitge has been released: Science as a product of a chain of human reactions
The first season of [RE]accions Bellvitge, the new audiovisual series from IDIBELL, premieres with four episodes.
The 11th edition of CaixaImpulse Health Innovation selects two IDIBELL projects, led by Ancor Serrano and Sara Preciado
Two IDIBELL researchers, Sara Preciado and Ancor Serrano, will receive funding from the CaixaImpulse program to promote their respective research and innovation projects in health.
Possible explanation found for the loss of efficacy of a common drug against type II diabetes
A study offers an explanation for the loss of effectiveness of sulfonylureas, one of the most common treatments for type II diabetes.